Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ALT | NASDAQ | USD | Real-time | |
ALT1 | BIVA | MXN | Delayed | |
3G0 | TradeGate | EUR | Delayed | |
3G0 | Frankfurt | EUR | Delayed |
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Mitchel B. Sayare | 73 | 2010 | Independent Chairman |
Philip L. Hodges | 52 | 2017 | Independent Director |
Vipin K. Garg | 63 | 2018 | President, CEO & Director |
Klaus O. Schafer | 74 | 2017 | Independent Director |
Diane Kathryn Jorkasky | 72 | 2020 | Independent Director |
John M. Gill | 72 | 2004 | Independent Director |
Rohit Loomba | - | 2022 | Member of Mash Scientific Advisory Board |
Mazen Noureddin | - | 2022 | Member of Mash Scientific Advisory Board |
Catherine Angell Sohn | 71 | 2023 | Independent Director |
Wayne F. Pisano | 69 | 2018 | Independent Director |
Caroline M. Apovian | - | 2022 | Member of Obesity Scientific Advisory Board |
Louis J. Aronne | 68 | 2022 | Member of Obesity Scientific Advisory Board |
Robert F. Kushner | - | 2022 | Member of Obesity Scientific Advisory Board |
Naga Chalasani | - | 2022 | Member of Mash Scientific Advisory Board |
Donna Ryan | - | 2022 | Member of Obesity Scientific Advisory Board |
Juan Pablo Frias | - | 2022 | Member of Obesity Scientific Advisory Board |
Samuel Klein | - | 2022 | Member of Obesity Scientific Advisory Board |
Lee M. Kaplan | - | 2023 | Member of Obesity Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review